• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.52% Nasdaq Up0.92%

    VALIC Company I Health Sciences (VCHSX)

    26.80 Down 0.64(2.33%) Jun 29

    Profile as of May 30, 2015Get Profile for:
    VALIC Company I Health Sciences
    AIG Retirement CO I2929 Allen Parkway A8-10Houston TX 77019
    Map
    Phone: 800-448-2542
    Fund Overview 
    Category:Health
    Fund Family:VALIC
    Net Assets:937.80M
    Year-to-Date Return:19.79%
    Yield:0.00%
    Morningstar Rating:5 stars
    Fund Inception Date:Nov 1, 2000
    Morningstar Style Box 
    Health
    [View Category Definition]
    View Top Health Funds
    About the Morningstar Style Box
    Management Information 
    Taymour R. Tamaddon
    Lead Manager since Feb 22, 2013
    Investment Information 
    Min Initial Investment:0
    Min Initial Investment, IRA:N/A
    Min Initial Investment, AIP:N/A
    Min Subsequent Investment:N/A
    Min Subsequent Investment, IRA:N/A
    Min Subsequent Investment, AIP:N/A
    VCHSX can be purchased from 0 brokerages.

    Fund Summary 
    The investment seeks long-term capital growth. The fund normally invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). It can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.

    Fund Operations 
    Last Dividend : 0.00
    Last Cap Gain (Feb 10, 2015) : 0.00
    Annual Holdings Turnover (Jun 24, 2015) : 59.00%
    Average for Category:52.90%
    Fees & Expenses 
    ExpenseVCHSXCategory Avg
    Annual Report Expense Ratio (net):1.11%1.37%
    Prospectus Net Expense Ratio:1.11%N/A
    Prospectus Gross Expense Ratio:1.11%N/A
    Max 12b1 Fee:N/AN/A
    Max Front End Sales Load:N/A5.28%
    Max Deferred Sales Load: N/A2.37%
    3 Yr Expense Projection*:353589
    5 Yr Expense Projection*:612905
    10 Yr Expense Projection*:1,3521,781
    * Per $10,000 invested